{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T16:23:23Z","timestamp":1777652603581,"version":"3.51.4"},"reference-count":56,"publisher":"American Medical Association (AMA)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Pediatr"],"published-print":{"date-parts":[[2018,6,1]]},"DOI":"10.1001\/jamapediatrics.2018.0240","type":"journal-article","created":{"date-parts":[[2018,4,30]],"date-time":"2018-04-30T16:30:52Z","timestamp":1525105852000},"page":"576","source":"Crossref","is-referenced-by-count":23,"title":["Patterns of Early Mental Health Diagnosis and Medication Treatment in a Medicaid-Insured Birth Cohort"],"prefix":"10.1001","volume":"172","author":[{"given":"Dinci","family":"Pennap","sequence":"first","affiliation":[{"name":"Department of Pharmaceutical Health Services Research, University of Maryland, Baltimore"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie M.","family":"Zito","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Health Services Research, University of Maryland, Baltimore"},{"name":"Department of Psychiatry, University of Maryland, Baltimore"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paramala J.","family":"Santosh","sequence":"additional","affiliation":[{"name":"Centre for Interventional Pediatric Psychopharmacology and Rare Diseases, Maudsley Hospital, London, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah E.","family":"Tom","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Health Services Research, University of Maryland, Baltimore"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eberechukwu","family":"Onukwugha","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Health Services Research, University of Maryland, Baltimore"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurence S.","family":"Magder","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Public Health, University of Maryland, Baltimore"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10","reference":[{"issue":"4","key":"poi180010r1","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1542\/peds.2013-1546","article-title":"National trends in psychotropic medication use in young children: 1994-2009.","volume":"132","author":"Chirdkiatgumchai","year":"2013","journal-title":"Pediatrics"},{"issue":"5","key":"poi180010r2","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1097\/00004583-200205000-00008","article-title":"National trends in the use of psychotropic medications by children.","volume":"41","author":"Olfson","year":"2002","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"1","key":"poi180010r3","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1001\/archpedi.157.1.17","article-title":"Psychotropic practice patterns for youth: a 10-year perspective.","volume":"157","author":"Zito","year":"2003","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"8","key":"poi180010r4","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1001\/jama.283.8.1025","article-title":"Trends in the prescribing of psychotropic medications to preschoolers.","volume":"283","author":"Zito","year":"2000","journal-title":"JAMA"},{"issue":"10","key":"poi180010r5","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1111\/jcpp.2011.52.issue-10","article-title":"Trends in psychopathology across the adolescent years: what changes when children become adolescents, and when adolescents become adults?","volume":"52","author":"Costello","year":"2011","journal-title":"J Child Psychol Psychiatry"},{"issue":"1","key":"poi180010r9","first-page":"3","article-title":"A perilous disconnect: antipsychotic drug use in very young children.","volume":"49","author":"Egger","year":"2010","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"2","key":"poi180010r10","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1002\/pds.v20.2","article-title":"Increasing off-label use of antipsychotic medications in the United States, 1995-2008.","volume":"20","author":"Alexander","year":"2011","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"7","key":"poi180010r11","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1001\/jama.290.7.905","article-title":"Pediatric drug labeling: improving the safety and efficacy of pediatric therapies.","volume":"290","author":"Roberts","year":"2003","journal-title":"JAMA"},{"issue":"10","key":"poi180010r12","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/j.pmrj.2013.08.601","article-title":"Balancing burdens and benefits: ethical issues of off-label prescription pharmaceutical use.","volume":"5","author":"Vox","year":"2013","journal-title":"PM R"},{"issue":"12","key":"poi180010r14","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1176\/appi.ps.53.12.1508","article-title":"Datapoints: use of multiple psychotropic drugs by Medicaid-insured and privately insured children.","volume":"53","author":"Martin","year":"2002","journal-title":"Psychiatr Serv"},{"issue":"9","key":"poi180010r15","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1176\/appi.ps.55.9.1049","article-title":"Comparative prevalence of psychotropic medications among youths enrolled in the SCHIP and privately insured youths.","volume":"55","author":"Safer","year":"2004","journal-title":"Psychiatr Serv"},{"issue":"12","key":"poi180010r16","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1001\/archpsyc.56.12.1073","article-title":"A 14-month randomized clinical trial of treatment strategies for attention-deficit\/hyperactivity disorder.","volume":"56","author":"The MTA Cooperative Group","year":"1999","journal-title":"Arch Gen Psychiatry"},{"issue":"5","key":"poi180010r17","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1056\/NEJMoa013171","article-title":"Risperidone in children with autism and serious behavioral problems.","volume":"347","author":"McCracken","year":"2002","journal-title":"N Engl J Med"},{"key":"poi180010r18","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.neuropharm.2004.06.021","article-title":"Understanding the neurobiological consequences of early exposure to psychotropic drugs: linking behavior with molecules.","volume":"47","author":"Carlezon","year":"2004","journal-title":"Neuropharmacology"},{"issue":"5-6","key":"poi180010r19","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.ijdevneu.2004.06.002","article-title":"Altering the course of neurodevelopment: a framework for understanding the enduring effects of psychotropic drugs.","volume":"22","author":"Andersen","year":"2004","journal-title":"Int J Dev Neurosci"},{"issue":"1","key":"poi180010r20","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1542\/peds.2008-2598","article-title":"Prevalence and treatment of mental disorders among US children in the 2001-2004 NHANES.","volume":"125","author":"Merikangas","year":"2010","journal-title":"Pediatrics"},{"issue":"21","key":"poi180010r21","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.1056\/NEJMsa1413512","article-title":"Trends in mental health care among children and adolescents.","volume":"372","author":"Olfson","year":"2015","journal-title":"N Engl J Med"},{"issue":"3","key":"poi180010r22","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1001\/2013.jamapediatrics.401","article-title":"Recent trends in childhood attention-deficit\/hyperactivity disorder.","volume":"167","author":"Getahun","year":"2013","journal-title":"JAMA Pediatr"},{"issue":"1","key":"poi180010r23","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1002\/pds.3897","article-title":"Antipsychotic prescribing for behavioral disorders in US youth: physician specialty, insurance coverage, and complex regimens.","volume":"25","author":"Burcu","year":"2016","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"12","key":"poi180010r24","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1176\/appi.ajp.2010.10040570","article-title":"National trends in outpatient psychotherapy.","volume":"167","author":"Olfson","year":"2010","journal-title":"Am J Psychiatry"},{"issue":"1","key":"poi180010r25","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1001\/jamapsychiatry.2013.3074","article-title":"National trends in the mental health care of children, adolescents, and adults by office-based physicians.","volume":"71","author":"Olfson","year":"2014","journal-title":"JAMA Psychiatry"},{"issue":"4","key":"poi180010r26","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1007\/s10826-013-9761-y","article-title":"Trends in psychotropic medication use for Medicaid-enrolled preschool children.","volume":"23","author":"Fontanella","year":"2014","journal-title":"J Child Fam Stud"},{"issue":"3","key":"poi180010r27","doi-asserted-by":"publisher","first-page":"524","DOI":"10.2105\/AJPH.2014.302258","article-title":"Psychotropic drug use among preschool children in the Medicaid program from 36 states.","volume":"105","author":"Garfield","year":"2015","journal-title":"Am J Public Health"},{"issue":"9","key":"poi180010r28","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1001\/jamapsychiatry.2015.0500","article-title":"Treatment of young people with antipsychotic medications in the United States.","volume":"72","author":"Olfson","year":"2015","journal-title":"JAMA Psychiatry"},{"key":"poi180010r29","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.jad.2013.12.011","article-title":"Gender differences in major depressive disorder: results from the Netherlands Study of Depression and Anxiety.","volume":"156","author":"Schuch","year":"2014","journal-title":"J Affect Disord"},{"issue":"4","key":"poi180010r30","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1097\/01.jcp.0000130558.86125.5b","article-title":"A comparison of risperidone-induced weight gain across the age span.","volume":"24","author":"Safer","year":"2004","journal-title":"J Clin Psychopharmacol"},{"issue":"6","key":"poi180010r31","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1176\/ajp.2006.163.6.1026","article-title":"Internalizing behaviors in 4-year-old children exposed in utero to psychotropic medications.","volume":"163","author":"Misri","year":"2006","journal-title":"Am J Psychiatry"},{"issue":"16","key":"poi180010r32","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1056\/NEJMoa0803531","article-title":"Cognitive function at 3 years of age after fetal exposure to antiepileptic drugs.","volume":"360","author":"Meador","year":"2009","journal-title":"N Engl J Med"},{"issue":"1","key":"poi180010r34","first-page":"69","article-title":"Accuracy of diagnoses of schizophrenia in Medicaid claims.","volume":"43","author":"Lurie","year":"1992","journal-title":"Hosp Community Psychiatry"},{"issue":"7","key":"poi180010r36","first-page":"2121","article-title":"Addiction: part I, benzodiazepines\u2014side effects, abuse risk and alternatives.","volume":"61","author":"Longo","year":"2000","journal-title":"Am Fam Physician"},{"issue":"1","key":"poi180010r37","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.jaac.2013.09.001","article-title":"Trends in the parent-report of health care provider-diagnosed and medicated attention-deficit\/hyperactivity disorder: United States, 2003-2011.","volume":"53","author":"Visser","year":"2014","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"3","key":"poi180010r38","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1001\/archpedi.156.3.217","article-title":"How common is attention-deficit\/hyperactivity disorder? incidence in a population-based birth cohort in Rochester, Minn.","volume":"156","author":"Barbaresi","year":"2002","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"4","key":"poi180010r39","doi-asserted-by":"publisher","first-page":"e20160430","DOI":"10.1542\/peds.2016-0430","article-title":"Patterns of comorbidity among girls with ADHD: a meta-analysis.","volume":"138","author":"Tung","year":"2016","journal-title":"Pediatrics"},{"issue":"3","key":"poi180010r41","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1542\/peds.106.3.533","article-title":"Stimulant treatment in Maryland public schools.","volume":"106","author":"Safer","year":"2000","journal-title":"Pediatrics"},{"issue":"4","key":"poi180010r42","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1542\/peds.108.4.1033","article-title":"Clinical practice guideline: treatment of the school-aged child with attention-deficit\/hyperactivity disorder.","volume":"108","author":"American Academy of Pediatrics","year":"2001","journal-title":"Pediatrics"},{"issue":"8","key":"poi180010r43","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.jaac.2016.05.015","article-title":"Combined stimulant and guanfacine administration in attention-deficit\/hyperactivity disorder: a controlled, comparative study.","volume":"55","author":"McCracken","year":"2016","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"6","key":"poi180010r45","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1089\/cap.2015.0247","article-title":"Pediatric antipsychotic use and outcomes monitoring.","volume":"27","author":"Santosh","year":"2017","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"10","key":"poi180010r46","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1001\/jamapsychiatry.2013.2053","article-title":"Antipsychotics and the risk of type 2 diabetes mellitus in children and youth.","volume":"70","author":"Bobo","year":"2013","journal-title":"JAMA Psychiatry"},{"issue":"8","key":"poi180010r47","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1016\/j.jaac.2017.04.004","article-title":"Concomitant use of atypical antipsychotics with other psychotropic medication classes and the risk of type 2 diabetes mellitus.","volume":"56","author":"Burcu","year":"2017","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"4","key":"poi180010r48","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1001\/archpediatrics.2010.48","article-title":"Metabolic screening in children receiving antipsychotic drug treatment.","volume":"164","author":"Morrato","year":"2010","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"3","key":"poi180010r49","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1089\/cap.2013.0094","article-title":"Atypical antipsychotic use among Medicaid-insured children and adolescents: duration, safety, and monitoring implications.","volume":"24","author":"Burcu","year":"2014","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"3","key":"poi180010r50","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1176\/appi.ps.201700177","article-title":"The impact of a state Medicaid peer-review authorization program on pediatric use of antipsychotic medications.","volume":"69","author":"Pennap","year":"2018","journal-title":"Psychiatr Serv"},{"issue":"3","key":"poi180010r52","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/S0002-7138(09)61063-3","article-title":"The prevalence of behavior problems in 3-year-old children.","volume":"19","author":"Earls","year":"1980","journal-title":"J Am Acad Child Psychiatry"},{"issue":"5","key":"poi180010r53","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1097\/00004583-198909000-00001","article-title":"Isle of Wight revisited: twenty-five years of child psychiatric epidemiology.","volume":"28","author":"Rutter","year":"1989","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"3","key":"poi180010r54","doi-asserted-by":"publisher","first-page":"e630","DOI":"10.1542\/peds.2012-3588","article-title":"ADHD and learning disabilities in former late preterm infants: a population-based birth cohort.","volume":"132","author":"Harris","year":"2013","journal-title":"Pediatrics"},{"issue":"9","key":"poi180010r55","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1016\/S0025-6196(11)62594-9","article-title":"Early life risk factors for attention-deficit\/hyperactivity disorder: a population-based cohort study.","volume":"79","author":"St Sauver","year":"2004","journal-title":"Mayo Clin Proc"},{"issue":"4","key":"poi180010r56","doi-asserted-by":"publisher","first-page":"e788","DOI":"10.1542\/peds.2010-1187","article-title":"Gender, attention-deficit\/hyperactivity disorder, and reading disability in a population-based birth cohort.","volume":"126","author":"Yoshimasu","year":"2010","journal-title":"Pediatrics"},{"key":"poi180010r13","author":"Wilson","year":"2009"},{"key":"poi180010r33","volume-title":"Psychiatric Pharmacosciences of Children and Adolescents","author":"Popper","year":"1987"},{"key":"poi180010r35","volume-title":"Child & Adolescent Mental Health: A Practical, All-in-One Guide","author":"Shatkin","year":"2015"},{"key":"poi180010r51","first-page":"51","volume-title":"Recent Research in Developmental Psychopathology","author":"Garrison","year":"1985"},{"key":"poi180010r6","unstructured":"CareyB. Debate over children and psychiatric drugs. New York Times. February 6, 2007. http:\/\/www.nytimes.com\/2007\/02\/15\/us\/15bipolar.html. Accessed March 15, 2018."},{"key":"poi180010r7","unstructured":"SchwarzA. Still in a crib, yet being given antipsychotics. New York Times. December 10, 2015. https:\/\/www.nytimes.com\/2015\/12\/11\/us\/psychiatric-drugs-are-being-prescribed-to-infants.html. Accessed March 15, 2018."},{"key":"poi180010r8","unstructured":"WilsonD. Child\u2019s ordeal shows risks of psychosis drugs for young. New York Times. September 1, 2010. http:\/\/www.nytimes.com\/2010\/09\/02\/business\/02kids.html?_r=2&hp. Accessed March 15, 2018."},{"key":"poi180010r40","unstructured":"American Academy of Child and Adolescent Psychiatry. Children with learning disorders. https:\/\/www.aacap.org\/App_Themes\/AACAP\/docs\/facts_for_families\/16_children_with_learning_disabilities.pdf. Published August 2013. Accessed January 16, 2018."},{"key":"poi180010r44","unstructured":"AllenKD, HendricksT; Center for Health Care Strategies, State Policy Advocacy and Reform Center. Medicaid and children in foster care. https:\/\/childwelfaresparc.files.wordpress.com\/2013\/03\/medicaid-and-children-in-foster-care.pdf. Published March 2013. Accessed January 16, 2018."}],"container-title":["JAMA Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamapediatrics\/fullarticle\/2678192","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,6,4]],"date-time":"2018-06-04T16:58:48Z","timestamp":1528131528000},"score":1,"resource":{"primary":{"URL":"http:\/\/archpedi.jamanetwork.com\/article.aspx?doi=10.1001\/jamapediatrics.2018.0240"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,1]]},"references-count":56,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,6,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamapediatrics.2018.0240","relation":{},"ISSN":["2168-6203"],"issn-type":[{"value":"2168-6203","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6,1]]}}}